Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 20/20 | 0.77 |
| ▸ | LIFR | P42702 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.57 |
| ▸ | HSD17B13 | Q7Z5P4 | 1/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4344145 | 0.92 | NR1H4 (0.65) | NR1H4LIFRCYP1A2CYP2C9 | |
| SCHEMBL4952961 | 0.89 | NR1H4 (0.77) | NR1H4LIFRCYP1A2CYP2C9HSD17B13 | |
| SCHEMBL3641386 | 0.88 | NR1H4 (0.75) | NR1H4LIFRCYP1A2CYP2C9HSD17B13 | |
| SCHEMBL30080606 | 0.87 | NR1H4 (0.74) | NR1H4LIFRHSD17B13 | |
| SCHEMBL4332555 | 0.87 | NR1H4 (0.77) | NR1H4LIFRCYP1A2CYP2C9 | |
| SCHEMBL2000419 | 0.87 | NR1H4 (1.00) | NR1H4LIFRCYP1A2CYP2C9NR1I2 | |
| SCHEMBL3638746 | 0.86 | NR1H4 (0.65) | NR1H4LIFRCYP1A2CYP2C9HSD17B13 | |
| SCHEMBL4332513 | 0.86 | NR1H4 (0.77) | NR1H4CYP1A2CYP2C9 | |
| SCHEMBL4336014 | 0.86 | NR1H4 (0.77) | NR1H4LIFRCYP1A2CYP2C9NR1I2 | |
| SCHEMBL4339748 | 0.85 | NR1H4 (0.75) | NR1H4CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2079307-A2 | FARNESOID X RECEPTOR AGONISTS | SmithKline Beecham Corporation (US) | 2009-07-22 | — | — | EP | claimed |
| WO-2008051942-A2 | FARNESOID X RECEPTOR AGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-05-02 | — | — | WO | claimed |
| EP-2079307-A2 | FARNESOID X RECEPTOR AGONISTS | SmithKline Beecham Corporation (US) | 2009-07-22 | — | — | EP | disclosed |
| WO-2008051942-A2 | FARNESOID X RECEPTOR AGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-05-02 | — | — | WO | disclosed |